GlassScriptPhysician profile
Erik Pedro Munoz
NPI 1851053979
$3,368.65
in general payments reported to CMS, 2019-2025
18 companies · $1,215 in 2025
The $1,215 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $721 · 2024: $1,433 · 2025: $1,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $922.15 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Edwards Lifesciences Corporation | $592.71 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $473.79 | 2023-2025 | Evenity, Repatha, Repatha |
| Glaxosmithkline, LLC. | $244.60 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $197.77 | 2024-2025 | Wegovy |
| Abbvie INC. | $166.27 | 2024-2025 | |
| Exact Sciences Corporation | $129.99 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $128.81 | 2024 | Kyphon Express II Kyphopak Tray |
| Indivior INC. | $123.07 | 2023-2024 | Sublocade |
| Lilly USA, LLC | $103.48 | 2023-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $81.85 | 2023-2025 | |
| Abbott Laboratories | $68.26 | 2024-2025 | Proclaim, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.26 | 2024 | |
| Xeris Pharmaceuticals, INC. | $25.28 | 2025 | Recorlev |
| Digestive Care, INC. | $23.43 | 2025 | Pertzye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.29 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $15.19 | 2025 | |
| Idorsia Pharmaceuticals US INC | $13.45 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.